Cargando…

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

BACKGROUND: It is unclear whether asthma and asthma medications increase or decrease the risk of severe COVID-19, and this is particularly true for patients with severe asthma receiving biologics. OBJECTIVES: The aim of this study was to assess incidence and disease course of COVID-19 in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eger, Katrien, Hashimoto, Simone, Braunstahl, Gert Jan, Brinke, Anneke ten, Patberg, Kornelis W., Beukert, Annelies, Smeenk, Frank, van der Sar–van der Brugge, Simone, Weersink, Els J.M., Bel, Elisabeth H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833566/ https://www.ncbi.nlm.nih.gov/pubmed/33388603 http://dx.doi.org/10.1016/j.rmed.2020.106287

Ejemplares similares

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial
por: van der Meer, Akke-Nynke, et al.
Publicado: (2021)

Management of the patient with eosinophilic asthma: a new era begins
por: de Groot, Jantina C., et al.
Publicado: (2015)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Asthma and COVID-19: do we finally have answers?
por: Eger, Katrien, et al.
Publicado: (2021)

Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma
por: Kroes, Johannes A., et al.
Publicado: (2022)

Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations
por: van Bragt, Job J. M. H., et al.
Publicado: (2021)

SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma
por: van Bragt, Job J.M.H., et al.
Publicado: (2021)

The Female Preponderance to Cough Hypersensitivity Syndrome: Another Clue Pointing to the Role of TRPV1 in Cough
por: Patberg, Kornelis W.
Publicado: (2011)

Do-not-intubate status and COVID-19 mortality in patients admitted to Dutch non-ICU wards
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?
por: Eger, Katrien, et al.
Publicado: (2022)

Clinical profile of patients with adult-onset eosinophilic asthma
por: de Groot, Jantina C., et al.
Publicado: (2016)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report
por: Kroes, Johannes Anthon, et al.
Publicado: (2022)

Patient perceptions of the re-usable Respimat(®) Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
por: Dreher, Michael, et al.
Publicado: (2021)

Recovery after admission with COVID-19 pneumonia – A follow-up study
por: van der Sar-van der Brugge, Simone, et al.
Publicado: (2023)

Diet quality, food intake and incident adult-onset asthma: a Lifelines Cohort Study
por: Visser, Edith, et al.
Publicado: (2023)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics
por: Kroes, Johannes A., et al.
Publicado: (2023)

Consultation performance of general practitioners when supported by an asthma/COPDC-service
por: Annelies, Lucas EM, et al.
Publicado: (2012)

What bothers severe asthma patients most? A paired patient–clinician study across seven European countries
por: Ainsworth, Ben, et al.
Publicado: (2023)

A reintroduction of environmental mite allergen control strategies for asthma treatment and the debate on their effectiveness
por: van Boven, Frank E., et al.
Publicado: (2019)

Robot-assisted thoracoscopic lobectomy as treatment of a giant bulla
por: Roemers, Rosa, et al.
Publicado: (2017)

COVID-19 vaccination acceptance, safety and side-effects in European patients with severe asthma
por: Bossios, Apostolos, et al.
Publicado: (2023)

The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands
por: van den Berg, Jan Willem K., et al.
Publicado: (2022)

Implementing integrated care guidelines in asthma and COPD: It ain't easy!
por: Witte, Jan A., et al.
Publicado: (2023)

Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper
por: Fieten, Karin B., et al.
Publicado: (2022)

Airway Inflammation Before and After Bronchial Thermoplasty in Severe Asthma
por: Wijsman, Pieta C, et al.
Publicado: (2022)

Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology
por: van der Sar, Iris G., et al.
Publicado: (2023)

Characteristics of severe asthma patients on biologics: a real-life European registry study
por: Principe, Stefania, et al.
Publicado: (2023)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course
por: Miedema, Jelle, et al.
Publicado: (2021)

STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life
por: Witte, Jan A., et al.
Publicado: (2022)

Pulmonary function and health-related quality of life after COVID-19 pneumonia
por: van der Sar - van der Brugge, S., et al.
Publicado: (2021)

The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer
por: Schulkes, Karlijn J. G., et al.
Publicado: (2017)

Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)

Circulating adipokine levels and COVID-19 severity in hospitalized patients
por: Flikweert, Antine W., et al.
Publicado: (2022)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

Healthcare utilization and indirect cost of treatment associated with severe allergic asthma in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kl52730j0ud4fhisvgqa4esdej